1. 25 – 26 March
2014
London
Linking Academic Clinical and Commercial Worlds
© 2014 Captum Capital Limited. All worldwide rights reserved.
Post Conference Summary

2. SENSORS IN MEDICINE 2014
Sensor technology is having a significant impact on healthcare
practice. From critical point-of-care, to diabetes monitoring, cancer and
infectious disease diagnosis through to lifestyle changes for better
health, sensor applications are at the fore front. Sensors in Medicine is
an international conference series which brings together leading
academics, clinicians and commerce to explore these exciting
applications and their impact in healthcare.
This slide presentation provides a flavor of Sensors in Medicine 2014
for the benefit of those who were unable to attend, and to introduce
the conference series to everyone who is considering joining us in
2015.
Michael Brand
Conference Chair
S E N S O R S I N M E D I C I N E 2 0 1 4

3.  Promote innovative new commercial sensor technology
 Highlight leading academic research near to commercial use
 Provide a platform to showcase emerging sensor companies
 Explore trends in medical applications of sensor technology
 Facilitate formation of partnerships for investment and technology transfer
CONFERENCE OBJECTIVES
S E N S O R S I N M E D I C I N E 2 0 1 4

4. THE COMMITTEE
Dr. Michael Brand
Captum Capital
Limited
Dr. Stuart Hendry
Consultant
Dr. Danny O’Hare
Imperial College,
London
Dr. Michael Pringle
Formerly, Siemens
Healthcare Diagnostics
Prof. Chris Van Hoof
imec
S E N S O R S I N M E D I C I N E 2 0 1 4

5. VENUE
Royal Geographic Society
1 Kensington Gore, London, SW7 2AR.
Ondaatje Theatre
S E N S O R S I N M E D I C I N E 2 0 1 4
The Conference took place on the entire
ground floor of Lowther Lodge, built in 1874

6. Tuesday 25th March
8:30 am Registration & Coffee
9:00 am Introduction
9:10 am Keynote: Dr. Marc Bailey
9:45 am 1. Digital Health
1:00 pm Lunch
2:00 pm 2. Innovation Technology
5:30 pm Break
6:00 pm Reception
8:30 pm Close
Wednesday 26th March
8:30 am Registration & Coffee
9:00 am Introduction
9:10 am Keynote: Dr. Thomas Keller
9:45 am 3. Breath Analysis
1:00 pm Lunch
2:00 pm 4. Emerging Companies
5:00 pm Close
PROGRAM
S E N S O R S I N M E D I C I N E 2 0 1 4

7. KEYNOTE: NEW SENSOR TECHNOLOGIES AND
MHEALTH
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Marc Bailey
Nokia

8. Digital Health
S E N S O R S I N M E D I C I N E 2 0 1 4
Chaired by:
Prof. Chris Van Hoof
Imec
University of Leuven

9. IMPROVING PATIENT OUTCOMES THROUGH
DIGITAL HEALTH
S E N S O R S I N M E D I C I N E 2 0 1 4
Ingestible Sensor Integrated with Medicines
Don Cowling
Proteus Digital
Health

10. TOWARDS SMARTPHONE CONNECTED
DIAGNOSTICS FOR INFECTIOUS DISEASES
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Rachel McKendry
University College London
“Emerging infections and antibiotic
resistance rank among the gravest threats to
human health alongside global warming and
terrorism”

11. PRACTICAL APPLICATIONS OF WEARABLE
SENSORS IN CLINICAL RESEARCH
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Michael Marschollek
Peter L. Reichertz Institute
for Medical Informatics
University of
Braunschweig

12. SENSOR ADAPTATION FOR CONTINUOUS IN
BODY AND ON BODY MONITORING
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Pankaj
Vadgama
Queen Mary
University of
London

13. PRINTED SENSORS FOR THE HEALTHCARE
SECTOR
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Laura Lopez
CETEMMSA

14. SENSOR DEVELOPMENT FOR MEDICAL
APPLICATIONS
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Christopher
Dawson
The
Technology
Partnership

15. Innovation Technology
S E N S O R S I N M E D I C I N E 2 0 1 4
Chaired by:
Prof. Martyn Boutelle
Imperial College
Dr. Danny O’Hare
Imperial College

16. MICROENGINEERED DEVICES FOR BIOMEDICAL
RESEARCH
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Nancy Albritton
University of North
Carolina

17. DESIGNING NANOMATERIALS FOR
ULTRASENISITVE BIOSENSING
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Molly Stevens
Imperial College
The Stevens Group - Nanomaterials as Diagnostic Platforms
www.stevensgroup.org/index.php/research/nanomaterials

18. MICROPROBE ARRAYS FOR MINIMALLY INVASIVE
CONTINUOUS GLUCOSE MONITORING IN DERMAL
INTERSTITIAL FLUID
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Sanjiv Sharma
Imperial College

19. DROPLET MICROFLUIDICS: TOWARDS ULTRA-HIGH
THROUGHPUT BIOLOGICAL EXPERIMENTATION
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Andrew deMello
Swiss Federal Institute of
Technology
ETH Zürich

20. MULTIPLEXED INFECTIOUS DISEASE TESTING:
SOUND POINT OF CARE DIAGNOSTICS
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Jon Cooper
University of Glasgow

21. Panel Discussion
S E N S O R S I N M E D I C I N E 2 0 1 4
Chaired by:
Dr. Michael Brand
Sensor100

22. CHALLENGES OF CONTINUOUS IN-VIVO SENSING
S E N S O R S I N M E D I C I N E 2 0 1 4
What does concentration in tissue mean?
Dr. Danny O’Hare, Imperial College
What are the effects of sensor implantation on the tissue?
Prof. Martyn Boutelle, Imperial College
How should you protect your sensor from tissue?
Prof. Pankaj Vadgama, Queen Mary University of London
What is required to have validated your in-vivo sensor?
Prof. Tony Cass, Imperial College

23. KEYNOTE: SENSOR OPPORTUNITIES IN
MEDICINE DEVELOPMENT
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Thomas Keller
Glaxo Smith Kline

24. Breath Analysis
S E N S O R S I N M E D I C I N E 2 0 1 4
Chaired by:
Dr. Michael Pringle
Formerly Siemens
Healthcare Diagnostics

25. SENSOR BASED BREATH ANALYSIS
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Roland Pohle
Siemens
Corporate
Research &
Technology

26. POINT OF CARE DIAGNOSTICS BASED ON
ORGANIC AND PRINTED TECHNOLOGIES
S E N S O R S I N M E D I C I N E 2 0 1 4
Prof. Tony Killard
University of the
West of England

27. SPEAKER FEEDBACK
S E N S O R S I N M E D I C I N E 2 0 1 4
Just to reiterate that the Sensors in Medicine was, for
me, one of the most focussed and relevant meetings that
I have been to in some time and I found it enormously
useful and would be keen to attend on a regular basis.
Professor Tony Killard, UWE

28. ON THE POTENTIAL OF ION MOBILITY
SPECTROMETRY FOR MEDICAL APPLICATIONS
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Wolfgang
Vautz
ISAS-e.V

29. FAIMS: A BREATHALYZER FOR DISEASE
S E N S O R S I N M E D I C I N E 2 0 1 4
Billy Boyle
Owlstone

30. Emerging Companies
S E N S O R S I N M E D I C I N E 2 0 1 4
Chaired by:
Dr. Shaw Fox
Sphere Medical

31. SMART PHONE ENABLED ACOUSTIC
BIOSENSORS
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Dale Athey
OJ-Bio

32. ELECTROCHEMICAL DETECTION OF DNA AT
DIRECTLY HEATED ELECTRODES
S E N S O R S I N M E D I C I N E 2 0 1 4
Dr. Lars Kruger
Gensoric
Just wanted to say thank you for organizing the
conference. We have had some really great follow-
up discussions with potential partners. So coming
to London was really worth it.
Dr. Lars Kruger, Gensoric GmbH

33. NOVEL PHOTONIC CHIP BASED NON-INVASIVE
BIOSENSOR TECHNOLOGY
S E N S O R S I N M E D I C I N E 2 0 1 4
Professor Gin Jose
University of Leeds

34. Point of Care Diagnostics
S E N S O R S I N M E D I C I N E 2 0 1 4
Chaired by:
Dr. Shaw Fox
Sphere Medical

35. S E N S O R S I N M E D I C I N E 2 0 1 4
Affordable sensors to detect microorganisms using
reagentless and label-less impedance spectroscopy
Summary
• Impedance spectroscopy and low cost
screen printing used to detect presence of
P. aeruginosa.
• The electrodes are not modified (i.e. no
reagents or labels are used)
• Significant changes occur to the
impedance after 24 hrs growth of P.
aeruginosa. Changes are related to the
presence of phenazine electroactive
metabolites such as pyocyanin, which are
not produced by S. aureus, H. influenzae
or C. albicans.
• Analysing the whole impedance spectrum
could result in changes that are
characteristic of other microorganisms.
Further Information
Contact:
Andrew Ward:
andrew.c.ward@strath.ac.uk
Prof. P. Connolly:
patricia.connolly@strath.ac.uk
Dr. N. P. Tucker:
nick.tucker@strath.ac.uk
Further Reading:
Ward et al. (2014), PLoS One Vol 9 Iss 3
Patents:
Detection approach covered by patent: WO2009136157
Sensors in Medicine 2014, London
Example
Electrode
Dr. Andrew Ward

36. POINT OF CARE TESTING OF NO METABOLITES
S E N S O R S I N M E D I C I N E 2 0 1 4
Professor M.
Gabriela Almeida
Instituto Superior
de Saúde Egas
Moniz

37. S E N S O R S I N M E D I C I N E 2 0 1 4
IMEL
WT
MU
*atserepi@imel.demokritos.gr
aInstitute of Nanoscience & Nanotechnology,
NCSR “Demokritos”, Aghia Paraskevi, Greece
b Foundation of Biomedical Research, Academy of
Athens, Greece
c National Technical University of Athens, Physics
Department, Athens, Greece
# Current address: Nano-Group, ECS, University
of Southampton, UK
Dr. Despina Moschou
University of Southampton

38. DELIVERING A PORTABLE, QUANTITATIVE,
RAPID DIAGNOSTIC SYSTEM FOR POINT OF
CARE DIAGNOSTICS
S E N S O R S I N M E D I C I N E 2 0 1 4
Courtney Nicholson
AgPlus Diagnostics

39. DELEGATE FEEDBACK
S E N S O R S I N M E D I C I N E 2 0 1 4
The event was excellent.
Dr D F Chowdhury, Nemaura Pharma
I thoroughly enjoyed this meeting. I felt there was a good
variety of speakers - I loved the Panel Discussion. The
location was perfect.
Niamh Brannelly, University of the West of England
Keep [the Conference series] going!
Anonymous delegate

40. POSTER COMPETITION
Winners
 Buffer capacity of blood: a lab-on-a-chip approach
Sahir Gandhi, Imperial College, London
 Photonic chip enabled non-invasive glucose biosensor
Tarun Kakkar, University of Leeds
 Development of a CMOS-integrated tunneling magneto-resistance
biosensor for lab-on-a-chip sepsis diagnostics
Dr. Eike Moritz Eggeling, AIT Austrian Institute of Technology GmbH
 Continuous contact-free monitoring using piezoelectric sensor
Roman Karasik, Earlysense Ltd, Israel
S E N S O R S I N M E D I C I N E 2 0 1 4
The Poster Competition was sponsored by:
Medical Research Council Technology
The four most innovative posters, judged by the delegates,
each received a cash award of £200
Sahir Gandhi

41. EXHIBITION
S E N S O R S I N M E D I C I N E 2 0 1 4

42. EXHIBITOR FEEDBACK
S E N S O R S I N M E D I C I N E 2 0 1 4
We are very interested in attending the conference again
next year as sponsors and would be even more delighted
with it if we could get an opportunity to talk.
Leonie Hilliard, Scienion AG
It’s great to hear that you’ll be holding a Sensors in
Medicine 2015. My colleagues Dr Heather Murton and Dr
Jenny Hannant came back with nothing but praise for the
conference. We expect to be able to live demos of our
Handheld Molecular Diagnostic Lab by the time 2015 rolls
around, so please do keep us in mind for speaker
opportunities.
Maggie Love, QuantuMDx Group Limited

43. RECEPTION
S E N S O R S I N M E D I C I N E 2 0 1 4

44. WORKSHOP: STARTING AND GROWING A
SENSOR COMPANY
Program:
Legal issues – Susan Laws, Duane Morris
Sources of finance – Michael Brand, Captum Capital
Protecting IP – Robert Carpmael, Marks & Clerk
Case study: Drinksafe – Christopher Jones, Imperial College
Partnering – Michael Pringle, formerly Siemens Healthcare Diagnostics
Networking – Tony Jones, OneNucleus
Case study: SCANurse - Anil Vaidya
Exit routes – Michael Brand, Captum Capital
S E N S O R S I N M E D I C I N E 2 0 1 4
The Workshop was held on Thursday 27 March at the
Department of Bioengineering, Imperial College

45. MEDIA PARTNERS
S E N S O R S I N M E D I C I N E 2 0 1 4
Sensors in Medicine is proud to partner with:
Sensors in Medicine social networks:

46. S E N S O R S I N M E D I C I N E 2 0 1 4
The 3rd Annual Sensors in Medicine Conference
24-25 March 2015
South Kensington, London
Expressions of interest are invited from:
• Speakers
• Poster Exhibitors
• Exhibition Sponsors
• Partners
• Delegates
Join the Mailing List for Program updates

47. ABOUT SENSOR 100
 Sensor100 is a global network of people and organisations
active in research, development and commercialisation of bio-
sensors and chemo-sensors
 The primary objective of Sensor100 is to facilitate the transfer of
sensor technology from the lab to commercial use
 The Sensors in Medicine Annual Conference series is organised
by Sensor100
 The free monthly eNewsletter is distributed by email to network
members in over 70 countries worldwide
www.sensor100.com
S E N S O R S I N M E D I C I N E 2 0 1 4
www.sensor100.com

48. m
Sensor100 is managed by:
Captum Capital Limited
Cumberland House
35 Park Row
Nottingham NG1 6EE
United Kingdom
t: +44 (0) 115 988 6154
www.captum.com
S E N S O R S I N M E D I C I N E 2 0 1 4
For more information, contact:
Dr. Michael Brand
www.captum.com